Investigating the neuroprotective effects of histone deacetylase inhibitors in Parkinson's disease
Parkinson's disease (PD) is the most common movement disorder and the second most common neurodegenerative disease affecting around 4 million people worldwide. Movement symptoms in PD are primarily due to degeneration of dopaminergic nigrostriatal neurons. These symptoms can be partially contro...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2014
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.650706 |